Announcing an Innovative Carpal Tunnel Syndrome Treatment Program Release and Relief
This program is designed to evaluate, and definitively treat patients with chronic carpal tunnel symptoms in 1 day! By using ultrasound for both diagnostic and therapeutic purposes we are now able to reliably and comfortably provide patients expedited symptom relief.
Carpal tunnel syndrome (CTS) is a result of a chronic compression of the median nerve. Ninety percent of patients present with a classic story of numbness, pain, tingling in the median nerve distribution of the hand that is worse at night, while driving, or while reading a newspaper. Classic physical exam findings (Tinels and Phalens) combined with the above history make the CTS diagnosis greater than 80% probable.
While nonoperative treatment in the form of splints, nonsteroidal anti-inflammatories, and injections can be useful in the first couple of months after symptom onset, symptoms greater than 6 months rarely respond adequately to nonoperative treatment. The chronic ischemia that results from nerve compression leads to irreversible intrinsic changes to the nerve. These intrinsic changes make it even more difficult to perfuse the nerve, and therefore symptoms can only be reliably relieved by nerve decompression. Several prospective randomized studies have demonstrated the superior efficacy of surgical versus nonsurgical treatment for CTS greater than 6 months duration.
Release and Relief is a program designed to care for Carpel Tunnel Syndrome – Evaluation and Treatment in ONE Day.
If you have carpal tunnel syndrome (CTS) and are considering a surgical procedure, Micro-invasive Carpal Tunnel Release (CTR) with the SX-One MicroKnife® may be right for you. Developed by doctors at the Mayo Clinic, the SX-One MicroKnife® is the breakthrough device that allows ultrasound-guided CTR to be performed through a tiny incision.